Avid Radiopharmaceuticals, Inc. Company Profile
Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of major chronic human diseases. Based in Philadelphia, PA, the companyâs lead program is a molecular imaging agent for amyloid plaque that could lead to earlier detection and better evaluation of drugs designed to prevent or reverse amyloid plaque build-up in the brain. Avid is currently conducting Phase III clinical studies of florbetapir for imaging amyloid plaques in Alzheimer's disease, and is in Phase I and II trials with 18F-AV-133 for imaging the vesicular monoamine transporter (VMAT2) in diseases involving dopaminergic degeneration (Parkinson's disease and Dementia with Lewy Bodies) and beta cell dysfunction (Type I and Type II Diabetes Mellitus). For more information, please visit www.avidrp.com.
News Articles
European Commission approves Eli Lilly-Avid Amyvid diagnostic radiopharmaceutical
Eli Lilly and Company and Avid Radiopharmaceuticals have announced the approval of Amyvid (Florbetapir (18F)) solution for injection in European Union to detect the beta-amyloid neuritic plaque densit...
European Commission approves Avid Radiopharmaceuticals diagnostic for Alzheimer’s disease
Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly, has received marketing authorisation from the European Commission for Amyvid as a diagnostic radiopharmaceutical indicated for positr...
Eli Lilly Receives Positive CHMP Opinion For Amyvid
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) announced that the company and its subsidiary, Avid Radiopharmaceuticals Inc., received a positive opinion from the Committee for Medicinal Product...
Avid, Eli Lilly announce availability of Amyvid in US
Avid Radiopharmaceuticals and Eli Lilly and Company have announced the availability of Amyvid (Florbetapir F 18 Injection) to imaging centers in markets surrounding 16 manufacturing sites in the US.
Lilly Alzheimer’s diagnostic approved for use in EU
Lilly's Amylin is the first and only diagnostic tool approved for use in the EU that can show the presence or absence of beta-amyloid neuritic plaque density in the brain. Eli Lilly and its subsidiar...
Important Class Action Deadline for Avid Technology Shareholders, Says the Rosen Law Firm -- AVID
NEW YORK, April 26, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds investors of the important May 24, 2013 lead plaintiff deadline in the class action lawsuit on behalf purchasers of the securit...
Rosen Law Firm Reminds Avid Tech Shareholders of May 24 Class Action Deadline -- AVID
NEW YORK, May 10, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. reminds investors of the important May 24, 2013 lead plaintiff deadline in the class action lawsuit on behalf purchasers of the sec...
NEW YORK, March 15, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Avid Technology, Inc. ("Avid" or the "Company") who...
Drugs and Medications
Iodotopesodium iodide i 131 capsules usp [Bracco Diagnostics Inc.]
IODOTOPESodium Iodide I 131 Capsules USP
Xenon xe 133 gasfor diagnostic use [Bristol-Myers Squibb]
XENON Xe 133 GASFOR DIAGNOSTIC USE
Sodium iodide i 131 [Mallinckrodt Inc.]
Sodium Iodide I 131 CapsulesTherapeutic
Technetium tc 99m medronate [Jubilant DraxImage Inc]
Technescan hdp kit for the preparation of technetium tc 99m oxidronate [Mallinckrodt Inc.]
TECHNESCAN HDP Kit for the Preparation of Technetium Tc 99m Oxidronate
PubMed Articles
Use of florbetapir-PET for imaging beta-amyloid pathology.
The ability to identify and quantify brain β-amyloid could increase the accuracy of a clinical diagnosis of Alzheimer disease.
A hand-held beta imaging probe for FDG.
OBJECTIVES: Advances in radiopharmaceuticals and clinical understanding have escalated the use of intraoperative gamma probes in surgery. However, most probes on the market are non-imaging gamma probe...
Polymeric Nanoparticles of FMISO: Are Nano-Radiopharmaceuticals better than conventional ones?
Nanotechnology has been the last frontier in the diagnoses and treatment of many diseases, especially in oncology. The use of nanoparticles of radiopharmaceuticals may represent the future of Nuclear...
PET radiopharmaceuticals in radiation treatment planning - Synthesis and biological characteristics.
During the last decade several different PET radiopharmaceuticals entered into the clinic and positron emission tomography (PET) became an important tool for staging of cancer patients and assessing r...
In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery.
Intravaginal (ivag) delivery, which is a proven way to confer local protection against STDs contracted via the reproductive tract, is complicated by the mucus gel barrier, the hormone cycle, and the h...
Clinical Trials
Antiarrhythmics Versus Implantable Defibrillators (AVID)
To evaluate if use of an implantable cardiac defibrillator (ICD) results in reduction in total mortality, when compared with conventional pharmacological therapy, in patients resuscitated...
Combination Targeted Radiotherapy in Neuroendocrine Tumors
RESEARCH PLAN / BACKGROUND AND SIGNIFICANCE: Tumors originating from the neuroendocrine system, although relatively rare, may be life threatening. In cases where the disease has metastasi...
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
18F ion is a positron emitting bone radiopharmaceuticals. The skeletal uptake of 18F relies on the exchange of hydroxyl ions in the hydroxyapatit crystal which is an indicator of bone meta...
Companies
Founded in 2004, Avid Radiopharmaceuticals, Inc. is a product-focused molecular imaging company that is a pioneer in developing radiopharmaceuticals for imaging Alzheimer's disease pathology. Two of A...
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of maj...
Avid Bioservices provides a comprehensive range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid manufactures cGMP commercial product, as well as clinical s...
The Council on Radionuclides and Radiopharmaceuticals (CORAR) is an association comprised of companies in the United States and Canada who manufacture and distribute radiopharmace...
ATLAB Pharma SAS is a French biotechnology company based in Nantes. ATLAB is developing a pipeline of targeted anti-cancer drugs including antibodies, Lutetium-177 beta-emitting r...
More Information about "Avid Radiopharmaceuticals, Inc." on BioPortfolio
We have published hundreds of Avid Radiopharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Avid Radiopharmaceuticals, Inc. Clinical Trials and PubMed Articles about Avid Radiopharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avid Radiopharmaceuticals, Inc. Companies in our database. You can also find out about relevant Avid Radiopharmaceuticals, Inc. Drugs and Medications on this site too.
